Abstract
Medical advances over the last decades have led to a growing patient population with end-stage liver disease and transplanted livers. These patients might present for elective or emergency surgery. In these patients several aspects need to be considered in order to provide safe anesthesia. This chapter focuses on the preoperative and intraoperative anesthetic management of patients with end-stage liver disease or after liver transplantation subjected to nontransplant surgery. Liver dysfunction, liver disease related organ malfunctions, laboratory testing, immunosuppression, and many other issues are set in context to the choice of anesthetics, intraoperative monitoring, and postoperative care. With a careful evaluation of the physiological and pharmacological specifications of the transplanted liver, the side effects of immunosuppression, the risk of infection, and potential graft dysfunction, general anesthesia can be carried out without compromising the dysfunctional or transplanted liver during nontransplant surgery.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Hanje AJ, Patel T. Preoperative evaluation of patients with liver disease. Nat Clin Pract Gastroenterol Hepatol. 2007;4:266–76.
Friedman LS. Surgery in the patient with liver disease. Trans Am Clin Climatol Assoc. 2010;121:192–204.
Deiner S, Silverstein JH. Anesthesia for geriatric patients. Minerva Anestesiol. 2011;77:180–9.
Jones TL, O’Beirne J, Goode A, Harrison S. Anaesthesia for caesarean section in a patient with Budd-Chiari syndrome and hepatopulmonary syndrome post liver transplantation. Int J Obstet Anesth. 2011;20:169–73.
Hall TH, Dhir A. Anesthesia for liver transplantation. Semin Cardiothorac Vasc Anesth. 2013;17:180–94.
Zafirova Z, O’connor M. Hepatic encephalopathy: current management strategies and treatment, including management and monitoring of cerebral edema and intracranial hypertension in fulminant hepatic failure. Curr Opin Anaesthesiol. 2010;23:121–7.
Ayoub T. Pulmonary hypertension in liver transplant. Curr Opin Organ Transplant. 2011;16:331–7.
Gines P, Schrier RW. Renal failure in cirrhosis. N Engl J Med. 2009;361:1279–90.
Biancofiore G, Mandell MS, Rocca GD. Perioperative considerations in patients with cirrhotic cardiomyopathy. Curr Opin Anaesthesiol. 2010;23:128–32.
Tripodi A, Mannucci PM. The coagulopathy of chronic liver disease. N Engl J Med. 2011;365:147–56.
Lisman T, Porte RJ. Rebalanced hemostasis in patients with liver disease: evidence and clinical consequences. Blood. 2010;116:878–85.
Hoetzel A, Ryan H, Schmidt R. Anesthetic considerations for the patient with liver disease. Curr Opin Anaesthesiol. 2012;25:340–7.
Kim SY, Yim HJ, Park SM, Kim JH, Jung SW, Kim JH, et al. Validation of a Mayo post-operative mortality risk prediction model in Korean cirrhotic patients. Liver Int. 2011;31:222–8.
Cho HC, Jung HY, Sinn DH, Choi MS, Koh KC, Paik SW, et al. Mortality after surgery in patients with liver cirrhosis: comparison of Child-Turcotte-Pugh, MELD and MELDNa score. Eur J Gastroenterol Hepatol. 2011;23:51–9.
Neeff H, Mariaskin D, Spangenberg HC, Hopt UT, Makowiec F. Perioperative mortality after non-hepatic general surgery in patients with liver cirrhosis: an analysis of 138 operations in the 2000s using Child and MELD scores. J Gastrointest Surg. 2011;15:1–11.
Farnsworth N, Fagan SP, Berger DH, Awad SS. Child-Turcotte-Pugh versus MELD score as a predictor of outcome after elective and emergent surgery in cirrhotic patients. Am J Surg. 2004;188:580–3.
Ziser A, Plevak DJ, Wiesner RH, Rakela J, Offord KP, Brown DL. Morbidity and mortality in cirrhotic patients undergoing anesthesia and surgery. Anesthesiology. 1999;90:42–53.
Suman A, Carey WD. Assessing the risk of surgery in patients with liver disease. Cleve Clin J Med. 2006;73:398–404.
Telem DA, Schiano T, Goldstone R, Han DK, Buch KE, Chin EH, et al. Factors that predict outcome of abdominal operations in patients with advanced cirrhosis. Clin Gastroenterol Hepatol. 2010;8:451–7.
Ghaferi AA, Mathur AK, Sonnenday CJ, Dimick JB. Adverse outcomes in patients with chronic liver disease undergoing colorectal surgery. Ann Surg. 2010;252:345–50.
Thielmann M, Mechmet A, Neuhauser M, Wendt D, Tossios P, Canbay A, et al. Risk prediction and outcomes in patients with liver cirrhosis undergoing open-heart surgery. Eur J Cardiothorac Surg. 2010;38:592–9.
Marrocco-Trischitta MM, Kahlberg A, Astore D, Tshiombo G, Mascia D, Chiesa R. Outcome in cirrhotic patients after elective surgical repair of infrarenal aortic aneurysm. J Vasc Surg. 2011;53:906–11.
Sun FR, Wang Y, Wang BY, Tong J, Zhang D, Chang B. Relationship between model for end-stage liver disease score and left ventricular function in patients with end-stage liver disease. Hepatobiliary Pancreat Dis Int. 2011;10:50–4.
Tinti F, Umbro I, Mecule A, Rossi M, Merli M, Nofroni I, et al. RIFLE criteria and hepatic function in the assessment of acute renal failure in liver transplantation. Transplant Proc. 2010;42:1233–6.
Kao HK, Guo LF, Cheng MH, Chen IH, Liao CT, Fang KH, et al. Predicting postoperative morbidity and mortality by model for endstage liver disease score for patients with head and neck cancer and liver cirrhosis. Head Neck. 2011;33:529–34.
Fox CJ, Liu H, Kaye AD. The anesthetic implications of alcoholism. Int Anesthesiol Clin. 2011;49:49–65.
Ramachandran SK, Nafiu OO, Ghaferi A, Tremper KK, Shanks A, Kheterpal S. Independent predictors and outcomes of unanticipated early postoperative tracheal intubation after nonemergent, noncardiac surgery. Anesthesiology. 2011;115:44–53.
Garg RK. Anesthetic considerations in patients with hepatic failure. Int Anesthesiol Clin. 2005;43:45–63.
Bjornsson E. Review article: Drug-induced liver injury in clinical practice. Aliment Pharmacol Ther. 2010;32:3–13.
Reuben A, Koch DG, Lee WM. Drug-induced acute liver failure: results of a U.S. multicenter, prospective study. Hepatology. 2010;52:2065–76.
Lee WM, Squires Jr RH, Nyberg SL, Doo E, Hoofnagle JH. Acute liver failure: summary of a workshop. Hepatology. 2008;47:1401–15.
Juang SE, Chen CL, Liao WT, Wang CH, Cheng KW, Huang CJ, et al. Two cases of massive pleural effusion noted only after induction of anesthesia in living donor liver transplantation. J Anesth. 2011;25:418–21.
Mercky P, Sakr L, Heyries L, Lagrange X, Sahel J, Dutau H. Use of a tunnelled pleural catheter for the management of refractory hepatic hydrothorax: a new therapeutic option. Respiration. 2010;80:348–52.
Kim SH, Na S, Choi JS, Na SH, Shin S, Koh SO. An evaluation of diaphragmatic movement by M-mode sonography as a predictor of pulmonary dysfunction after upper abdominal surgery. Anesth Analg. 2010;110:1349–54.
Kim JA, Lee JJ, Kim CS, Chung IS, Gwak MS, Kim GS. Does general anesthesia with inhalation anesthetics worsen hypoxemia in patients with end-stage liver disease and an intrapulmonary shunt? Transplant Proc. 2011;43:1665–8.
Mukhtar NA, Fix OK. Portopulmonary hypertension. J Clin Gastroenterol. 2011;45:703–10.
Benza RL, Miller DP, Gomberg-Maitland M, Frantz RP, Foreman AJ, Coffey CS, et al. Predicting survival in pulmonary arterial hypertension: insights from the Registry to Evaluate Early and Long-Term Pulmonary Arterial Hypertension Disease Management (REVEAL). Circulation. 2010;122:164–72.
De Pietri L, Montalti R, Begliomini B, Reggiani A, Lancellotti L, Giovannini S, et al. Pulmonary hypertension as a predictor of postoperative complications and mortality after liver transplantation. Transplant Proc. 2010;42:1188–90.
Kim EJ, Shin MS, Oh KY, Kim MG, Shin KC, Park YM, et al. Successful management of portopulmonary hypertension with beraprost. Eur J Gastroenterol Hepatol. 2010;22:1503–5.
Melgosa MT, Ricci GL, Garcia-Pagan JC, Blanco I, Escribano P, Abraldes JG, et al. Acute and long-term effects of inhaled iloprost in portopulmonary hypertension. Liver Transpl. 2010;16:348–56.
Cartin-Ceba R, Swanson K, Iyer V, Wiesner RH, Krowka MJ. Safety and efficacy of ambrisentan for the treatment of portopulmonary hypertension. Chest. 2011;139:109–14.
Mandell MS, Lindenfeld J, Tsou MY, Zimmerman M. Cardiac evaluation of liver transplant candidates. World J Gastroenterol. 2008;14:3445–51.
Maithel SK, Kneuertz PJ, Kooby DA, Scoggins CR, Weber SM, Martin RC, et al. Importance of low preoperative platelet count in selecting patients for resection of hepatocellular carcinoma: a multi-institutional analysis. J Am Coll Surg. 2011;212:638–48.
Burroughs AK, Matthews K, Qadiri M, Thomas N, Kernoff P, Tuddenham E, et al. Desmopressin and bleeding time in patients with cirrhosis. Br Med J (Clin Res Ed). 1985;291:1377–81.
Schemel WH. Unexpected hepatic dysfunction found by multiple laboratory screening. Anesth Analg. 1976;55:810–2.
Kang JG, Ko JS, Kim GS, Gwak MS, Kim YR, Lee SK. The relationship between inhalational anesthetic requirements and the severity of liver disease in liver transplant recipients according to three phases of liver transplantation. Transplant Proc. 2010;42:854–7.
Kim YK, Shin WJ, Song JG, Jun IG, Kim HY, Seong SH, et al. Factors associated with changes in coagulation profiles after living donor hepatectomy. Transplant Proc. 2010;42:2430–5.
Yang LQ, Song JC, Irwin MG, Song JG, Sun YM, Yu WF. A clinical prospective comparison of anesthetics sensitivity and hemodynamic effect among patients with or without obstructive jaundice. Acta Anaesthesiol Scand. 2010;54:871–7.
Okawa H, Ono T, Hashiba E, Tsubo T, Ishihara H, Hirota K. Use of bispectral index monitoring for a patient with hepatic encephalopathy requiring living donor liver transplantation: a case report. J Anesth. 2011;25:117–9.
Toprak HI, Sener A, Gedik E, Ucar M, Karahan K, Aydogan MS, et al. Bispectral index monitoring to guide end-tidal isoflurane concentration at three phases of operation in patients with end-stage liver disease undergoing orthotopic liver transplantation. Transplant Proc. 2011;43:892–5.
Schumann R, Hudcova J, Bonney I, Cepeda MS. Availability of anesthetic effect monitoring: utilization, intraoperative management and time to extubation in liver transplantation. Transplant Proc. 2010;42:4564–6.
Correia LM, Bonilha DQ, Gomes GF, Brito JR, Nakao FS, Lenz L, et al. Sedation during upper GI endoscopy in cirrhotic outpatients: a randomized, controlled trial comparing propofol and fentanyl with midazolam and fentanyl. Gastrointest Endosc. 2011;73:45–51.
Khamaysi I, William N, Olga A, Alex I, Vladimir M, Kamal D, et al. Sub-clinical hepatic encephalopathy in cirrhotic patients is not aggravated by sedation with propofol compared to midazolam: a randomized controlled study. J Hepatol. 2011;54:72–7.
Sharma P, Singh S, Sharma BC, Kumar M, Garg H, Kumar A, et al. Propofol sedation during endoscopy in patients with cirrhosis, and utility of psychometric tests and critical flicker frequency in assessment of recovery from sedation. Endoscopy. 2011;43:400–5.
Arslan M, Kurtipek O, Dogan AT, Unal Y, Kizil Y, Nurlu N, et al. Comparison of effects of anaesthesia with desflurane and enflurane on liver function. Singapore Med J. 2009;50:73–7.
Singhal S, Gray T, Guzman G, Verma A, Anand K. Sevoflurane hepatotoxicity: a case report of sevoflurane hepatic necrosis and review of the literature. Am J Ther. 2010;17:219–22.
Mesnil M, Capdevila X, Bringuier S, Trine PO, Falquet Y, Charbit J, et al. Long-term sedation in intensive care unit: a randomized comparison between inhaled sevoflurane and intravenous propofol or midazolam. Intensive Care Med. 2011;37:933–41.
Savitsky EA, Votey SR, Mebust DP, Schwartz E, Uner AB, McCain S. A descriptive analysis of 290 liver transplant patient visits to an emergency department. Acad Emerg Med. 2000;7:898–905.
Testa G, Goldstein RM, Toughanipour A, Abbasoglu O, Jeyarajah R, Levy MF, et al. Guidelines for surgical procedures after liver transplantation. Ann Surg. 1998;227:590–9.
Zeyneloglu P, Pirat A, Sulemanji D, Torgay A, Karakayali H, Arslan G. Perioperative anesthetic management for recipients of orthotopic liver transplant undergoing nontransplant surgery. Exp Clin Transplant. 2007;5:690–2.
Kaminski P, Bobrowska K, Pietrzak B, Bablok L, Wielgos M. Gynecological issues after organ transplantation. Neuro Endocrinol Lett. 2008;29:852–6.
Ota T, Rocha R, Wei LM, Toyoda Y, Gleason TG, Bermudez C. Surgical outcomes after cardiac surgery in liver transplant recipients. J Thorac Cardiovasc Surg. 2013;145:1072–6.
Kostopanagiotou G, Sidiropoulou T, Pyrsopoulos N, Pretto Jr EA, Pandazi A, Matsota P, et al. Anesthetic and perioperative management of intestinal and multivisceral allograft recipient in nontransplant surgery. Transpl Int. 2008;21:415–27.
Roy D, Ralley FE. Anesthetic management of a patient with dynamic left ventricular outflow tract obstruction with systolic anterior movement of the mitral valve undergoing redo-orthotopic liver transplantation. J Cardiothorac Vasc Anesth. 2012;26:274–6.
Carson KL, Hunt CM. Medical problems occurring after orthotopic liver transplantation. Dig Dis Sci. 1997;42:1666–74.
Duclos-Vallee JC, Sebagh M. Recurrence of autoimmune disease, primary sclerosing cholangitis, primary biliary cirrhosis, and autoimmune hepatitis after liver transplantation. Liver Transpl. 2009;15 Suppl 2:S25–34.
Gologorsky E, Pretto Jr EA, Fukazawa K. Coronary artery disease and its risk factors in patients presenting for liver transplantation. J Clin Anesth. 2013;25(8):618–23.
Neal DA, Tom BD, Luan J, Wareham NJ, Gimson AE, Delriviere LD, et al. Is there disparity between risk and incidence of cardiovascular disease after liver transplant? Transplantation. 2004;77:93–9.
Toivonen HJ. Anaesthesia for patients with a transplanted organ. Acta Anaesthesiol Scand. 2000;44:812–33.
Tinti F, Mitterhofer AP, Muiesan P. Liver transplantation: role of immunosuppression, renal dysfunction and cardiovascular risk factors. Minerva Chir. 2012;67:1–13.
Lucey MR, Terrault N, Ojo L, Hay JE, Neuberger J, Blumberg E, et al. Long-term management of the successful adult liver transplant: 2012 practice guideline by the American Association for the Study of Liver Diseases and the American Society of Transplantation. Liver Transpl. 2013;19:3–26.
Kostopanagiotou G, Smyrniotis V, Arkadopoulos N, Contis J, Briassoulis G, Kostopanagiotou E. Anaesthetic and perioperative management of paediatric organ recipients in nontransplant surgery. Paediatr Anaesth. 2003;13:754–63.
Pinho-Apezzato ML, Tannuri U, Tannuri AC, Mello ES, Lima F, Gibelli NE, et al. Multiple clinical presentations of lymphoproliferative disorders in pediatric liver transplant recipients: a single-center experience. Transplant Proc. 2010;42:1763–8.
De Diego JI, Prim MP, Hardisson D, Verdaguer JM, Jara P. Post-transplant lymphoproliferative disease in tonsils of children with liver transplantation. Int J Pediatr Otorhinolaryngol. 2001;58:113–8.
Colle I, Van VH, Troisi R, De HB. Transplanted liver: consequences of denervation for liver functions. Anat Rec A Discov Mol Cell Evol Biol. 2004;280:924–31.
Navasa M, Feu F, Garcia-Pagan JC, Jimenez W, Llach J, Rimola A, et al. Hemodynamic and humoral changes after liver transplantation in patients with cirrhosis. Hepatology. 1993;17:355–60.
Henderson JM, Millikan WJ, Hooks M, Noe B, Kutner MH, Warren WD. Increased galactose clearance after liver transplantation: a measure of increased blood flow through the denervated liver? Hepatology. 1989;10:288–91.
Mehrabi A, Golling M, Kashfi A, Boucsein T, Schemmer P, Gutt CN, et al. Negative impact of systemic catecholamine administration on hepatic blood perfusion after porcine liver transplantation. Liver Transpl. 2005;11:174–87.
Feng ZY, Zhang J, Zhu SM, Zheng SS. Is there any difference in anesthetic management of different post-OLT stage patients undergoing nontransplant organ surgery? Hepatobiliary Pancreat Dis Int. 2006;5:368–73.
Pedrosa ME, Montero EF, Nigro AJ. Liver microcirculation after selective denervation. Microsurgery. 2001;21:163–5.
Perseghin G, Regalia E, Battezzati A, Vergani S, Pulvirenti A, Terruzzi I, et al. Regulation of glucose homeostasis in humans with denervated livers. J Clin Invest. 1997;100:931–41.
Luzi L, Perseghin G, Regalia E, Sereni LP, Battezzati A, Baratti D, et al. Metabolic effects of liver transplantation in cirrhotic patients. J Clin Invest. 1997;99:692–700.
Pillai AA, Levitsky J. Overview of immunosuppression in liver transplantation. World J Gastroenterol. 2009;15:4225–33.
Sussmann NL, Vierling JM. Overview of immunosuppression in adult liver transplantation [Internet]. [updated 2013 Dec 16; cited 2013 Dec 29]. Available from: http://www.uptodate.com/contents/overview-of-immunosuppression-in-adult-liver-transplantation
Kostopanagiotou G, Smyrniotis V, Arkadopoulos N, Theodoraki K, Papadimitriou L, Papadimitriou J. Anesthetic and perioperative management of adult transplant recipients in nontransplant surgery. Anesth Analg. 1999;89:613–22.
Borde DP, Gandhe U, Hargave N, Pandey K. Perioperative management of emergency aortic valve replacement for infective endocarditis after liver transplantation. Ann Card Anaesth. 2013;16:227–9.
Pertek JP, Chaoui K, Junke E, Artis M, Coissard A, Frisoni A, et al. Effects of propofol on blood concentration of cyclosporine. Ann Fr Anesth Reanim. 1996;15:589–94.
Crosby E, Robblee JA. Cyclosporine-pancuronium interaction in a patient with a renal allograft. Can J Anaesth. 1988;35(3 Pt 1):300–2.
Ganjoo P, Tewari P. Oral cyclosporine-vecuronium interaction. Can J Anaesth. 1994;41:1017.
Tucker ON, Heaton N. The ‘small for size’ liver syndrome. Curr Opin Crit Care. 2005;11:150–5.
Serenari M, Cescon M, Cucchetti A, Pinna AD. Liver function impairment in liver transplantation and after extended hepatectomy. World J Gastroenterol. 2013;19:7922–9.
Colombari RC, de Ataide EC, Udo EY, Falcao AL, Martins LC, Boin IF. Neurological complications prevalence and long-term survival after liver transplantation. Transplant Proc. 2013;45:1126–9.
Amodio P, Biancardi A, Montagnese S, Angeli P, Iannizzi P, Cillo U, et al. Neurological complications after orthotopic liver transplantation. Dig Liver Dis. 2007;39:740–7.
Dhar R, Young GB, Marotta P. Perioperative neurological complications after liver transplantation are best predicted by pre-transplant hepatic encephalopathy. Neurocrit Care. 2008;8:253–8.
Saner FH, Sotiropoulos GC, Gu Y, Paul A, Radtke A, Gensicke J, et al. Severe neurological events following liver transplantation. Arch Med Res. 2007;38:75–9.
Yilmaz M, Cengiz M, Sanli S, Yegin A, Mesci A, Dinckan A, et al. Neurological complications after liver transplantation. J Int Med Res. 2011;39:1483–9.
Wang WL, Yang ZF, Lo CM, Liu CL, Fan ST. Intracerebral hemorrhage after liver transplantation. Liver Transpl. 2000;6:345–8.
Battaglia SE, Pretto JJ, Irving LB, Jones RM, Angus PW. Resolution of gas exchange abnormalities and intrapulmonary shunting following liver transplantation. Hepatology. 1997;25:1228–32.
De Wolf AM. Preoperative optimization of patients with liver disease. Curr Opin Anaesthesiol. 2005;18:325–31.
Donovan CL, Marcovitz PA, Punch JD, Bach DS, Brown KA, Lucey MR, et al. Two-dimensional and dobutamine stress echocardiography in the preoperative assessment of patients with end-stage liver disease prior to orthotopic liver transplantation. Transplantation. 1996;61:1180–8.
Carey EJ, Gautam M, Ingall T, Douglas DD. The effect of liver transplantation on autonomic dysfunction in patients with end-stage liver disease. Liver Transpl. 2008;14:235–9.
Lhuillier F, Dalmas ED, Gratadour PM, Cividjian AA, Boillot OC, Quintin L, et al. Spontaneous baroreflex cardiac sensitivity in end-stage liver disease: effect of liver transplantation. Eur J Anaesthesiol. 2006;23:426–32.
Turner S, Dhamarajah S, Bosomworth M, Bellamy MC. Effect of perioperative steroids on renal function after liver transplantation. Anaesthesia. 2006;61:253–9.
Junge G, Schewior LV, Kohler S, Neuhaus R, Langrehr JM, Tullius S, et al. Acute renal failure after liver transplantation: incidence, etiology, therapy, and outcome. Transplant Proc. 2006;38:723–4.
Romano TG, Schmidtbauer I, Silva FM, Pompilio CE, D’Albuquerque LA, Macedo E. Role of MELD score and serum creatinine as prognostic tools for the development of acute kidney injury after liver transplantation. PLoS One. 2013;8:e64089.
Faenza S, Arpesella G, Bernardi E, Faenza A, Pierucci E, Siniscalchi A, et al. Combined liver transplants: main characteristics from the standpoint of anesthesia and support in intensive care. Transplant Proc. 2006;38:1114–7.
Kallwitz ER. Metabolic syndrome after liver transplantation: preventable illness or common consequence? World J Gastroenterol. 2012;18:3627–34.
Kuo HT, Sampaio MS, Ye X, Reddy P, Martin P, Bunnapradist S. Risk factors for new-onset diabetes mellitus in adult liver transplant recipients, an analysis of the Organ Procurement and Transplant Network/United Network for Organ Sharing database. Transplantation. 2010;89:1134–40.
Meierhenrich R, Gauss A, Muhling B, Bracht H, Radermacher P, Georgieff M, et al. The effect of propofol and desflurane anaesthesia on human hepatic blood flow: a pilot study. Anaesthesia. 2010;65:1085–93.
Sockalingam I, Green DW. Mivacurium-induced prolonged neuromuscular block. Br J Anaesth. 1995;74:234–6.
Slota M, Green M, Farley A, Janosky J, Carcillo J. The role of gown and glove isolation and strict handwashing in the reduction of nosocomial infection in children with solid organ transplantation. Crit Care Med. 2001;29:405–12.
Braun F, Platz KP, Faendrich F, Kremer B, Mueller AR. Management of venous access problems before and after intestinal transplantation: case reports. Transplant Proc. 2004;36:392–3.
Jullien T, Valtier B, Hongnat JM, Dubourg O, Bourdarias JP, Jardin F. Incidence of tricuspid regurgitation and vena caval backward flow in mechanically ventilated patients. A color Doppler and contrast echocardiographic study. Chest. 1995;107:488–93.
Hatano E, Terajima H, Yabe S, Asonuma K, Egawa H, Kiuchi T, et al. Hepatic artery thrombosis in living related liver transplantation. Transplantation. 1997;64(10):1443–6.
Vivarelli M, Cucchetti A, La BG, Bellusci R, De VA, Nardo B, et al. Ischemic arterial complications after liver transplantation in the adult: multivariate analysis of risk factors. Arch Surg. 2004;139:1069–74.
Mueller EA, Kovarik JM, Koelle EU, Merdjan H, Johnston A, Hitzenberger G. Pharmacokinetics of cyclosporine and multiple-dose diclofenac during coadministration. J Clin Pharmacol. 1993;33:936–43.
Tallgren M, Olkkola KT, Seppala T, Hockerstedt K, Lindgren L. Pharmacokinetics and ventilatory effects of oxycodone before and after liver transplantation. Clin Pharmacol Ther. 1997;61:655–61.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2017 Springer Science+Business Media New York
About this chapter
Cite this chapter
Hoetzel, A. (2017). General Anesthesia for the Patient with End-Stage Liver Disease and Post Liver Transplantation. In: Subramaniam, K., Sakai, T. (eds) Anesthesia and Perioperative Care for Organ Transplantation. Springer, New York, NY. https://doi.org/10.1007/978-1-4939-6377-5_31
Download citation
DOI: https://doi.org/10.1007/978-1-4939-6377-5_31
Published:
Publisher Name: Springer, New York, NY
Print ISBN: 978-1-4939-6375-1
Online ISBN: 978-1-4939-6377-5
eBook Packages: MedicineMedicine (R0)